Home > Publications database > Exploiting synergistic drug interaction of ribonucleotide reductase and cell cycle checkpoint inhibitors for innovative therapy of pediatric bone tumors
 
Master Thesis DKFZ-2026-00999
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Exploiting synergistic drug interaction of ribonucleotide reductase and cell cycle checkpoint inhibitors for innovative therapy of pediatric bone tumors



2024

Masterarbeit, Friedrich-Schiller-Universität Jena, 2024  GO


Note: Masterarbeit, Friedrich-Schiller-Universität Jena, 2024
Contributing Institute(s):
  1. Translationale Pädiatrische Sarkomforschung (B410)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2024
Click to display QR Code for this record

The record appears in these collections:
Document types > Theses > Master Theses
Public records
Publications database
 Record created 2026-04-27, last modified 2026-05-27
Similar records



Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)
DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2605
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy